Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
ASX:IMR
Want to see AU:IMR full AI Analyst Report?
IMR Stock Chart & Stats
AU$1.64
--
Market closed
AU$1.64
--
Day’s Range― - ―
52-Week RangeAU$1.15 - AU$2.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)287.54K
Market Cap
AU$558.45M
Enterprise ValueAU$321.78M
Total Cash (Recent Filing)AU$40.81M
Total Debt (Recent Filing)AU$26.62M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Sep 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding320,947,020
10 Day Avg. Volume240,875
30 Day Avg. Volume287,535
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)27.34
Price to Sales (P/S)1042.05
P/FCF Ratio-15.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.78Price Target Upside69.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.07
Revenue Forecast (FY)AU$3.42M
Bulls Say, Bears Say
Bulls Say
Differentiated MRI-compatible TechnologyImricor's focus on MRI-compatible EP systems targets a structural shift away from X-ray fluoroscopy toward MRI-guided ablation. This specialized technology creates higher clinical barriers to entry, potential procedural advantages, and a durable niche that supports long-term product differentiation and pricing power.
Balance Sheet ImprovementEquity turning positive materially reduces immediate solvency risk versus prior years and improves credibility with lenders and partners. This structural improvement expands financing and operational options over the medium term, lowering short-term liquidation risk while the business pursues commercialization.
Progress In Cash Flow TrendA less-negative free cash flow trend suggests early traction on cost control or modest commercialization progress. While still cash consumptive, an improving cash-flow slope is a durable indicator that operational fixes or scale effects are beginning to reduce runway pressure if sustained for several quarters.
Bears Say
Collapsing Revenue & Negative Gross ProfitSevere revenue decline and persistently negative gross profit point to weak product uptake and poor unit economics. This structural revenue shortfall undermines operating leverage and means scaling will require both demand restoration and improvements to product margins to achieve sustainable profitability.
Heavy Ongoing Cash BurnSustained multi‑million-dollar negative operating and free cash flow materially shortens runway and forces recurrent external funding. Over the medium term this elevates refinancing, dilution, or covenant risks unless the company can reverse cash burn through revenue growth or marked cost reductions.
Elevated LeverageRising debt and a 2.3x debt-to-equity ratio increase refinancing and interest burdens while limiting strategic flexibility. Given ongoing losses and negative cash flow, leverage materially raises the likelihood of dilutive capital raises or strained lender terms over the coming months.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh News
IMR FAQ
What was Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price range in the past 12 months?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh lowest share price was AU$1.15 and its highest was AU$2.25 in the past 12 months.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap is AU$558.45M.
When is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date is Sep 01, 2026 which is in 86 days.
How were Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s earnings last quarter?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, beating the consensus estimate of -AU$0.032 by AU$0.032.
Is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh overvalued?
According to Wall Street analysts Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price is currently Undervalued.
Does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh pay dividends?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh does not currently pay dividends.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate is 0.
How many shares outstanding does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh have?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 320,947,020 shares outstanding.
What happened to Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price movement after its last earnings report?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh reported an EPS of AU$0 in its last earnings report, beating expectations of -AU$0.032. Following the earnings report the stock price went up 1.508%.
Which hedge fund is a major shareholder of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh?
Currently, no hedge funds are holding shares in AU:IMR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$2.78 (69.51% Upside)
AU$2.78 (69.51% Upside)
Blogger Sentiment
Bullish
AU:IMR Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
102.70%
12-Months-Change
Fundamentals
Return on Equity
-109.63%
Trailing 12-Months
Asset Growth
96.47%
Trailing 12-Months
Company Description
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR) Earnings & Revenues
IMR Stock 12 Month Forecast
Average Price Target
AU$2.78
▲(69.51% Upside)
Technical Analysis
Impedimed Limited
―
HeraMED Ltd.
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Options Prices
Currently, No data available
---